A caution: please do not discuss politics per se h
Post# of 72440
if Kevetrin works as we hope it will, it will be CHEAPER to treat people with Kevetrin either by itself or as an adjunct (co-therapy) -- because if it makes treatment more effective with fewer side effects, it means fewer procedures and therefore lots of cost savings.
So I think we need to wait until we find out what the clinical trial results are before we speculate as to what impact, if any, that changes in insurance will cause.